Prevacus Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $1.66M
Latest Deal Amount
  • Investors
  • 1

Prevacus General Information


Developer of pharmaceutical drugs designed to treat the effects of a mild traumatic brain injury and concussions. The company's drug commercialize and develops a ground-breaking proprietary formalization to treat and prevent the effects of a mild traumatic brain injury, enabling medical professionals with novel drug testing for neurodegenerative disorders, including Alzheimer's disease to evaluate the safety and efficacy of these drugs in preparation for bringing these products to market.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 1400 Village Square Boulevard
  • Suite 3 Number 414
  • Tallahassee, FL 32312
  • United States
+1 (850) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prevacus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 28-Feb-2013 $1.66M 00.000 Completed Generating Revenue
To view Prevacus’s complete valuation and funding history, request access »

Prevacus Executive Team (3)

Name Title Board Seat Contact Info
Jacob VanLandingham Ph.D Founder, President & Lead Scientific Consultant
Michael Lewandowski Chief Scientific Officer
Megan Munyon Director of Business Operations
To view Prevacus’s complete executive team members history, request access »

Prevacus Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prevacus Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Florida Institute for the Commercialization of Public Research Not-For-Profit Venture Capital 000 0000 000000 0
To view Prevacus’s complete investors history, request access »

Prevacus Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 (000 27-Jun-2019 00000 0000000 Biotechnology
To view Prevacus’s complete investments history, request access »